Cargando…

Prevalence of PALB2 mutations in Australian familial breast cancer cases and controls

INTRODUCTION: PALB2 is emerging as a high-penetrance breast cancer predisposition gene in the order of BRCA1 and BRCA2. However, large studies that have evaluated the full gene rather than just the most common variants in both cases and controls are required before all truncating variants can be inc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Thompson, Ella R., Gorringe, Kylie L., Rowley, Simone M., Wong-Brown, Michelle W., McInerny, Simone, Li, Na, Trainer, Alison H., Devereux, Lisa, Doyle, Maria A., Li, Jason, Lupat, Richard, Delatycki, Martin B., Mitchell, Gillian, James, Paul A., Scott, Rodney J., Campbell, Ian G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4539664/ https://www.ncbi.nlm.nih.gov/pubmed/26283626 http://dx.doi.org/10.1186/s13058-015-0627-7

Ejemplares similares

Reevaluation of the BRCA2 truncating allele c.9976A > T (p.Lys3326Ter) in a familial breast cancer context
por: Thompson, Ella R., et al.
Publicado: (2015)

Evaluating the breast cancer predisposition role of rare variants in genes associated with low-penetrance breast cancer risk SNPs
por: Li, Na, et al.
Publicado: (2018)

Investigation of monogenic causes of familial breast cancer: data from the BEACCON case-control study
por: Li, Na, et al.
Publicado: (2021)

Integration of tumour sequencing and case–control data to assess pathogenicity of RAD51C missense variants in familial breast cancer
por: Lim, Belle W. X., et al.
Publicado: (2022)

Exome sequencing of familial high-grade serous ovarian carcinoma reveals heterogeneity for rare candidate susceptibility genes
por: Subramanian, Deepak N., et al.
Publicado: (2020)

Molecular comparison of pure ovarian fibroma with serous benign ovarian tumours
por: Hunter, Sally M., et al.
Publicado: (2020)

Somatic inactivation of breast cancer predisposition genes in tumors associated with pathogenic germline variants
por: Lim, Belle W X, et al.
Publicado: (2022)

Analysis of RAD51D in Ovarian Cancer Patients and Families with a History of Ovarian or Breast Cancer
por: Thompson, Ella R., et al.
Publicado: (2013)

CONTRA: copy number analysis for targeted resequencing
por: Li, Jason, et al.
Publicado: (2012)

Cell cycle regulated transcription: from yeast to cancer
por: McInerny, Christopher J.
Publicado: (2016)

Ten Simple Rules for Curating and Facilitating Small Workshops
por: McInerny, Greg J.
Publicado: (2016)

52 degrees south: mental health services in the Falkland Islands
por: Rimicans, Karen, et al.
Publicado: (2018)

Evaluation of two population screening programmes for BRCA1/2 founder mutations in the Australian Jewish community: a protocol paper
por: Cousens, Nicole E, et al.
Publicado: (2021)

Germline whole exome sequencing of a family with appendiceal mucinous tumours presenting with pseudomyxoma peritonei
por: Lung, Mei Sim, et al.
Publicado: (2020)

No evidence for PALB2 methylation in high-grade serous ovarian cancer
por: Mikeska, Thomas, et al.
Publicado: (2013)

Copy number analysis by low coverage whole genome sequencing using ultra low-input DNA from formalin-fixed paraffin embedded tumor tissue
por: Kader, Tanjina, et al.
Publicado: (2016)

Tumour morphology predicts PALB2 germline mutation status
por: Teo, Z L, et al.
Publicado: (2013)

Exome Sequencing Identifies Rare Deleterious Mutations in DNA Repair Genes FANCC and BLM as Potential Breast Cancer Susceptibility Alleles
por: Thompson, Ella R., et al.
Publicado: (2012)

ESCRT Function in Cytokinesis: Location, Dynamics and Regulation by Mitotic Kinases
por: Bhutta, Musab S., et al.
Publicado: (2014)

A Complex Network of Interactions between Mitotic Kinases, Phosphatases and ESCRT Proteins Regulates Septation and Membrane Trafficking in S. pombe
por: Bhutta, Musab S., et al.
Publicado: (2014)

MicroRNA Genes and Their Target 3′-Untranslated Regions Are Infrequently Somatically Mutated in Ovarian Cancers
por: Ryland, Georgina L., et al.
Publicado: (2012)

Germline PALB2 Mutations in Cancers and Its Distinction From Somatic PALB2 Mutations in Breast Cancers
por: Hu, Zhe-Yu, et al.
Publicado: (2020)

Loss of heterozygosity: what is it good for?
por: Ryland, Georgina L., et al.
Publicado: (2015)

Anillin/Mid1p interacts with the ESCRT-associated protein Vps4p and mitotic kinases to regulate cytokinesis in fission yeast
por: Rezig, Imane M., et al.
Publicado: (2021)

The role of anillin/Mid1p during medial division and cytokinesis: from fission yeast to cancer cells
por: Rezig, Imane M., et al.
Publicado: (2022)

PALB2 (partner and localizer of BRCA2)
por: Hanenberg, Helmut, et al.
Publicado: (2018)

The TP53 mutation rate differs in breast cancers that arise in women with high or low mammographic density
por: Cheasley, Dane, et al.
Publicado: (2020)

Evolutionary Origin of Human PALB2 Germline Pathogenic Variants
por: Chian, Jia Sheng, et al.
Publicado: (2023)

How range shifts induced by climate change affect neutral evolution
por: McInerny, G.J., et al.
Publicado: (2009)

Evaluation of the association of heterozygous germline variants in NTHL1 with breast cancer predisposition: an international multi-center study of 47,180 subjects
por: Li, Na, et al.
Publicado: (2021)

Mutational landscape of mucinous ovarian carcinoma and its neoplastic precursors
por: Ryland, Georgina L., et al.
Publicado: (2015)

Erratum to: Mutational landscape of mucinous ovarian carcinoma and its neoplastic precursors
por: Ryland, Georgina L., et al.
Publicado: (2017)

PALB2 and breast cancer: ready for clinical translation!
por: Southey, Melissa C, et al.
Publicado: (2013)

PALB2 self-interaction controls homologous recombination
por: Buisson, Rémi, et al.
Publicado: (2012)

A rational approach to cancer therapy
por: Gorringe, Kylie L, et al.
Publicado: (2008)

Characterisation of PALB2 tumours through whole-exome and whole-transcriptomic analyses
por: Ng, Pei Sze, et al.
Publicado: (2021)

Assessment of PALB2 as a Candidate Melanoma Susceptibility Gene
por: Aoude, Lauren G., et al.
Publicado: (2014)

The Role of PALB2 in the DNA Damage Response and Cancer Predisposition
por: Nepomuceno, Thales C., et al.
Publicado: (2017)

Functional characterization of 84 PALB2 variants of uncertain significance
por: Wiltshire, Timothy, et al.
Publicado: (2019)

Structural Insight into the Mechanism of PALB2 Interaction with MRG15
por: Redington, Jennifer, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_uafi43639t2flitvi1rbc0v1ap